Oralics — Salivary Biomarker Intelligence

Mission

Oralics enables personalized, non-invasive, continuous health monitoring through salivary biomarkers, delivering evidence-based wellness insights in real time.

Vision

A world where everyone has a personal laboratory at home, transforming saliva into actionable health intelligence that empowers informed wellness decisions.

Oralics device packaging with sensor, charging cable, and saliva collection vials
Live signal · 1.2s
Personal baseline
Trend detected
Wellness indicators
Metabolism
Stress
Inflammation
AI insights
Your pattern, over time

The product

Meet Oralics — your personal saliva lab.

A compact sensor that reads multiple biomarkers from one saliva drop in minutes, then turns the signal into personalized trends and next steps.

The problem

Health testing is still invasive, slow, and episodic.

Blood draws and mail-in tests are costly and inconvenient. Results take days or weeks, while one-off snapshots miss the changes that happen between tests.

Consumers and wellness practitioners need an accessible way to follow stress, immunity, metabolism, inflammation, oral bacteria, and performance over time.

How it works

From one drop to personal health intelligence.

01

Collect

A single saliva sample — no swabs, no shipping, no cold chain.

02

Sense

Sensor reads a broad molecular fingerprint without reagents.

03

Infer

Machine-learning models correlate the spectral signal with gold-standard laboratory results.

04

Act

The companion app compares results with your baseline, symptoms, lifestyle, and habits.

Where it matters

Saliva is one of the body's most accessible windows into daily health.

Saliva reflects dynamic signals across immunity, inflammation, metabolism, hormones, oral bacteria, and daily performance — without a needle.

Stress & resilience

Follow alpha-amylase, DHEA-S, and personal trends around demanding days.

Metabolic health

Track insulin-related patterns alongside nutrition, sleep, and activity.

Immune health

Monitor SIgA and inflammation signals against an individual baseline.

Hormonal wellness

Surface changing testosterone and future hormone trends non-invasively.

Oral health

Read oral bacteria alongside other salivary biomarkers in one sample.

Performance & longevity

Connect objective saliva data with recovery, habits, and how you feel.

For investors

The intelligence layer for oral health.

Oralics is building the intelligence layer for continuous, non-invasive health monitoring.

Just as Fitbit transformed activity into continuous behavioral data, and CGMs transformed glucose into a real-time metabolic signal, Oralics is turning salivary biomarkers and oral microbiome signals into a longitudinal health intelligence platform.

The mouth is one of the body's richest biological interfaces — continuously reflecting changes across inflammation, metabolism, immunity, nutrition, and everyday wellness. Yet today, broad biomarker analysis remains invasive, episodic, and inaccessible to most consumers and providers.

Oralics changes that.

Using a simple saliva sample, AI-powered analysis, and longitudinal monitoring, Oralics delivers rapid, scalable insight into oral and systemic wellness — without the cost and latency of traditional labs.

1 drop
A single saliva sample
5 min
In-the-moment results
Platform
Hardware + AI + longitudinal data
7
Biomarker groups already validated

Market opportunity

Conservative · highly defensible
  • $1B+Projected oral microbiome products market by 2035
  • $14B+Projected human microbiome market by 2034

Market opportunity dashboard

A multi-layer TAM, anchored in the microbiome, expanding into digital health.

CoreAdjacentMacro
$15.2B
Core microbiome + saliva TAM
by 2035
$225B
Adjacent health-tech & AI TAM
by 2030
$1.31T
Macro tailwind
by 2030–31
$1.56T
Total combined TAM
across 8 layers

TAM by category

Market size · USD billions (log scale)

TAM composition

Where the dollars sit

  • Core· Microbiome + saliva
    $15B
  • Adjacent· AI + analytics + oral care
    $225B
  • Macro· Digital + preventive health
    $1.31T
  • Oral / Saliva Testing
    Core
    $5.5B
    2030
    Saliva collection and testing market
  • Microbiome Analysis
    Core
    $700M+
    2035
    Microbiome analysis and insights market
  • Human Microbiome (broader)
    Core
    $8–9B+
    2034–35
    Research, analytics, products, and platforms
  • Healthcare Predictive Analytics
    Adjacent
    $62B
    2030
    Aligned with longitudinal biomarker strategy
  • Oral Care
    Adjacent
    $53B+
    2030
    Large adjacent consumer health category
  • AI in Healthcare
    Adjacent
    $110B
    2030
    AI-driven insights and predictive systems
  • Digital Health
    Macro
    $573B+
    2030
    Remote monitoring and AI-powered health tools
  • Preventive Healthcare Tech
    Macro
    $585–742B
    2030–31
    Macro shift to proactive monitoring

Bars use a log scale so core microbiome categories stay legible alongside macro digital-health TAMs. Source projections from analyst reports across 2030–2035.

The platform

From a saliva signal to continuous health intelligence.

Oralics is building a wellness platform and a proprietary longitudinal biological dataset capable of powering:

  • Preventive wellness insights
  • Personalized wellness recommendations
  • Risk prediction models
  • Payer and employer health programs
  • Future biomarker discovery and therapeutic partnerships

The compounding loop

More users → more biological signal → better models → more useful personal insights → more users.

Over time, Oralics has the potential to become the system of record for oral health intelligence.

Why now

Healthcare is shifting from reactive care to continuous monitoring.

  • 01Consumers increasingly expect longitudinal health insights.
  • 02AI is unlocking pattern recognition across biological data at unprecedented scale.
  • 03Salivary biomarkers and the oral microbiome are emerging as rich signal layers for whole-body health.

Platform advantages

Five reasons Oralics compounds where others plateau.

01
Fast

Actionable insights in minutes, not weeks.

02
Accessible

Simple saliva-based workflow designed for broad adoption.

03
Scalable

No dependence on high-cost sequencing infrastructure.

04
Compounding

A proprietary longitudinal dataset that improves over time.

05
Defensible

Integrated hardware + AI + data network effects.

Roadmap

From MVP validation to continuous health intelligence.

Each phase compounds the last: data feeds models, models unlock indications, indications unlock clinical and payer partnerships.

Phase 01Complete

Proof of concept

  • Seven biomarker groups evaluated on the current wavelength range
  • Strong signals for secretory immunoglobulin A, testosterone, DHEA-S, and insulin
  • Additional signals for alpha-amylase, C-reactive protein, and 16 oral-bacteria species
  • Initial MEMS FT-MIR and machine-learning feasibility established
Phase 02 · NowIn progress

MVP validation

  • Four upgraded sensor prototypes with battery, Bluetooth, and data transfer
  • Longitudinal saliva testing against gold-standard laboratory results
  • Structured consumer research and in-home testing
  • MVP governance gate targeted for Q2 2027
Phase 03Planned

Product development

  • Commercial product design and factory tooling
  • Conversational AI and personalized wellness insights
  • Premium B2B entry through executive wellness and longevity clinics
  • Cost-down path toward a $499 consumer device
Phase 04Vision

Global platform

  • Mass production and global fulfillment
  • Predictive health monitoring across expanding biomarker panels
  • Recurring device and subscription revenue
  • Research expansion supported by longitudinal evidence

Founding team

World-class science meets proven technical execution.

Dr. Hend Alqaderi

Dr. Hend Alqaderi

Founder & CEO · Oral biology and salivary biomarker research

Tim Pastore

Tim Pastore

Chief Technology Officer · Optics, spectroscopy, AI, and product commercialization

Harvard-trained science · 50+ peer-reviewed publications · 10 US patents · $500M+ spectroscopy sales led

Help us put a personal saliva lab within reach.

We're talking to clinical partners, research collaborators, and mission-aligned investors. If that's you, we'd love to hear from you.